oxedrine, p-synephrine, bitter orange alkaloid · Evidence-based safety and harm-reduction overview.
| Also known as | oxedrine, p-synephrine, bitter orange alkaloid |
| Category | Nootropic |
| natural_source | Bitter orange (Citrus aurantium) peel |
| adrenergic_profile | Partial agonist at alpha and beta adrenergic receptors |
| potency_vs_ephedrine | Weaker sympathomimetic effect than ephedrine but similar mechanism |
| US legal status | Sold as a dietary supplement derived from bitter orange; not FDA-approved; forms a legal gray area after DMAA ban |
An alkaloid found in bitter orange peel. Acts as an adrenergic agonist (weaker than ephedrine). Often marketed as an DMAA alternative despite limited evidence of efficacy.
Synephrine is a sympathomimetic amine that acts as a partial agonist at alpha and beta adrenergic receptors, with preference for alpha-1 receptors in some tissues. This activation increases sympathetic tone, heart rate, and blood pressure. At typical supplement doses, effects are modest; potency is lower than ephedrine. In vivo human pharmacology remains incompletely characterized.
Synephrine is a naturally occurring alkaloid in citrus fruits, particularly bitter orange (Citrus aurantium). It gained prominence in Western supplement markets in the early 2000s as a legal replacement for banned ephedrine (1997) and later DMAA (2013). Marketing emphasizes natural origin and efficacy for weight loss and energy.
Minimal rigorous human studies. Some evidence for modest metabolic and mood effects. Often overstated compared to the weak evidence base. More research needed for reliable conclusions.
Bitter orange supplements typically provide 6-100 mg of synephrine per serving depending on extraction and concentration. No established clinical dosing exists for humans. Some formulas combine bitter orange with caffeine to enhance effects, but safety of such combinations in humans is minimally studied.
This is general research/context information, not medical advice or a recommended protocol.
Synephrine is often combined with caffeine in fat-loss supplements to amplify effects. Such combinations increase cardiovascular load without clear evidence of improved safety or efficacy compared to caffeine alone.
Regular caffeine and exercise. Proven safe and effective for alertness and metabolism; exercise provides superior fat loss and sustained benefits without cardiovascular unknowns.
See our recommended pickIf you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.
Compare testing optionsSynephrine is weaker and may carry lower risk, but both act on the sympathetic nervous system. Neither is well-studied for safety at scale; caution applies to both.
Limited evidence. Most trials show weak effects or no difference from placebo at typical supplement doses. Hype exceeds evidence.
Not recommended without medical oversight. Cardiovascular monitoring would be prudent, and long-term effects are unknown.
Bitter orange (Citrus aurantium) is a citrus fruit used in traditional medicine. The whole fruit is generally recognized as safe, but concentrated synephrine extracts carry sympathomimetic risks.
Synephrine is weaker than caffeine and acts primarily on adrenergic receptors rather than adenosine antagonism. Caffeine is far better studied and has a stronger established safety profile.
Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.
Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.